Decreased Oleic Acid and Marine n − 3 Polyunsaturated Fatty Acids in Tunisian Patients with Urothelial Bladder Cancer

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61, 69–90, 2011. doi: 10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, et al.: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63, 234–241, 2013. doi: 10.1016/j.eururo.2012.07.033.
   PubMed Web of Science ®Google Scholar
• Brinkman MT, Buntinx F, Kellen E, Dagnelie PC, Van Dongen MC, et al.: Dietary intake of micronutrients and the risk of developing bladder cancer: results from the Belgian case-control study on bladder cancer risk. Cancer Causes Control 22, 469–478, 2011. doi: 10.1007/s10552-010-9718-z.
   PubMed Web of Science ®Google Scholar
• Brinkman MT, Buntinx F, Kellen E, Van Dongen MC, Dagnelie PC, et al.: Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer risk. Eur J Cancer 47, 436–442, 2011. doi: 10.1016/j.ejca.2010.09.027.
   PubMed Web of Science ®Google Scholar
• Ben Fradj MK, Gargouri MM, Hammami MB, Ben Rhouma S, Kallel A, et al.: Bladder cancer is associated with low plasma 25-hydroxyvitamin D concentrations in Tunisian population. Nutr Cancer 68, 208–213, 2016. doi: 10.1080/01635581.2016.1134598.
   PubMed Web of Science ®Google Scholar
• Comba A, Lin YH, Eynard AR, Valentich MA, Fernandez-Zapico ME, et al.: Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev 30, 325–342, 2011. doi: 10.1007/s10555-011-9308-x.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56, 365–379, 2002.
   PubMed Web of Science ®Google Scholar
• Kuriki K, Wakai K, Matsuo K, Hiraki A, Suzuki T, et al.: Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 16, 2406–2415, 2007. doi: 10.1158/1055-9965.EPI-07-0655.
   PubMed Web of Science ®Google Scholar
• Bassett JK, Hodge AM, English DR, MacInnis R, and Giles GG: Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk. Cancer Causes Control 27, 759–773, 2016. doi: 10.1007/s10552-016-0753-2.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Tsubono Y, Otani T, Hanaoka T, Sobue T, et al.: long-chain n-3 polyunsaturated fatty acids, and risk of colorectal cancer in middle-aged Japanese: the JPHC study. Nutr Cancer 49, 32–40. 2004.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, et al.: Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer 67, 543–554, 2015. doi: 10.1080/01635581.2015.1015745.
   PubMed Web of Science ®Google Scholar
• Cao Y, Hou L, and Wang W: Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: a meta-analysis of prospective cohort studies. Int J Cancer 138, 1894–1904, 2016. doi: 10.1002/ijc.29938.
   PubMed Web of Science ®Google Scholar
• D’Eliseo D, Manzi L, Merendino N, and Velotti F: Docosahexaenoic acid inhibits invasion of human RT112 urinary bladder and PT45 pancreatic carcinoma cells via down-modulation of granzyme B expression. J Nutr Biochem 23, 452–457, 2012. doi: 10.1016/j.jnutbio.2011.01.010.
   PubMed Web of Science ®Google Scholar
• Parada B, Reis F, Cerejo R, Garrido P, Sereno J, et al.: Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer. Biomed Res Int 2013, 368178, 2013. doi: 10.1155/2013/368178.
   PubMed Web of Science ®Google Scholar
• McClinton S, Moffat LE, Horrobin DF, and Manku MS: Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 63, 314–316, 1991.
   PubMed Web of Science ®Google Scholar
• Allen NE, Appleby PN, Key TJ, Bueno-de-Mesquita HB, Ros MM, et al.: Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer 132, 635–644, 2013. doi: 10.1002/ijc.27643.
   PubMed Web of Science ®Google Scholar
• Hsairi M, Fakhfakh R, Ben Abdallah M, Jlidi R, et al.: [Assessment of cancer incidence in Tunisia 1993–1997]. Tunis Med 80, 57–64, 2002.
   PubMedGoogle Scholar
• Aounallah-Skhiri H, Traissac P, El Ati J, Eymard-Duvernay S, Landais E, et al.: Nutrition transition among adolescents of a south-Mediterranean country: dietary patterns, association with socio-economic factors, overweight and blood pressure. A cross-sectional study in Tunisia. Nutr J 10, 38, 2011. doi: 10.1186/1475-2891-10-38.
   PubMed Web of Science ®Google Scholar
• Greene FL, Page DL, Flemming ID, Fritz A, Balch CM, et al.: American Joint Committee on Cancer Staging Manual. New York: Springer-Verlag, 2002.
   Google Scholar
• Moser HW and Moser AB: Techniques in Diagnostic Human Biochemical Genetics. New York: Wiley, 1991, p. 177.
   Google Scholar
• Benjamini Y and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57, 289–300, 1995.
   Web of Science ®Google Scholar
• Colquhoun A: Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. J Urol 181, 1885–1893, 2009. doi: 10.1016/j.juro.2008.11.092.
   PubMed Web of Science ®Google Scholar
• Erickson KL and Hubbard NE: Fatty acids and breast cancer: the role of stem cells. Prostaglandins Leukot Essent Fatty Acids 82, 237–241, 2010. doi: 10.1016/j.plefa.2010.02.019.
   PubMed Web of Science ®Google Scholar
• Jing K, Wu T, and Lim K: Omega-3 polyunsaturated fatty acids and cancer. Anticancer Agents Med Chem 13, 1162–1177, 2013.
   PubMed Web of Science ®Google Scholar
• Kitano M, Mori S, Chen T, Murai T, and Fukushima S: Lack of promoting effects of alpha-linolenic, linoleic or palmitic acid on urinary bladder carcinogenesis in rats. Jpn J Cancer Res 86, 530–534, 1995.
   PubMedGoogle Scholar
• Oh YS, Lee HS, Cho HJ, Lee SG, Jung KC, et al.: Conjugated linoleic acid inhibits DNA synthesis and induces apoptosis in TSU-Pr1 human bladder cancer cells. Anticancer Res 23, 4765–4772, 2003.
   PubMed Web of Science ®Google Scholar
• Maggiora M, Bologna M, Cerù MP, Possati L, Angelucci A, et al.: An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int J Cancer 112, 909–919, 2004.
   PubMed Web of Science ®Google Scholar
• Imai N, Kawabe M, Tamano S, Doi Y, Nakashima H, et al.: Arachidonate-enriched triglyceride oil does not promote tumor development in a rat medium-term multi-organ carcinogenesis model. Food Chem Toxicol 50, 2780–2791, 2012. doi: 10.1016/j.fct.2012.05.004.
   PubMed Web of Science ®Google Scholar
• Danon A, Zenser TV, Thomasson DL, and Davis BB: Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res 46, 5676–5681, 1986.
   PubMed Web of Science ®Google Scholar
• Kim EY, Seo JM, Kim C, Lee JE, Lee KM, et al.: BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway. Free Radic Biol Med 49, 1072–1081, 2010. doi: 10.1016/j.freeradbiomed.2010.06.023.
   PubMed Web of Science ®Google Scholar
• Moussa O, Ciupek A, Watson DK, and Halushka PV: Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat 96, 41–44, 2011. doi: 10.1016/j.prostaglandins.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Seo JM, Cho KJ, Kim EY, Choi MH, Chung BC, et al.: Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp Mol Med 43, 129–137, 2011. doi: 10.3858/emm.2011.43.3.014.
   PubMed Web of Science ®Google Scholar
• Matsuyama M and Yoshimura R: Study of arachidonic Acid pathway in human bladder tumor. Subst Abuse 3, 99–107, 2009.
   PubMedGoogle Scholar
• Xu Y and Qian SY: Anti-cancer activities of ω-6 polyunsaturated fatty acids. Biomed J 37, 112–119, 2014. doi: 10.4103/2319-4170.131378.
   PubMedGoogle Scholar
• Tapiero H, Ba GN, Couvreur P, and Tew KD: Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 56, 215–222, 2002.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ, McCarty MF, Chatterjee S, Lavie CJ, and O’Keefe JH: A higher dietary ratio of long-chain omega-3 to total omega-6 fatty acids for prevention of COX-2-dependent adenocarcinomas. Nutr Cancer 66, 1279–1284, 2014. doi: 10.1080/01635581.2014.956262.
   PubMed Web of Science ®Google Scholar
• Sawyer MB and Field CJ: Possible mechanisms of ω-3 PUFA anti-tumour action. In: Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer. Diet and Cancer, Vol. 1. Calviello G and Serini S (eds.). Dordrecht, Netherlands: Springer, 2010.
   Google Scholar
• Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, and Salem N Jr: Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res 63, 132–152, 2016. doi: 10.1016/j.plipres.2016.05.001.
   PubMed Web of Science ®Google Scholar
• Delgado Y, Morales-Cruz M, Figueroa CM, Hernández-Román J, Hernández G, et al.: The cytotoxicity of BAMLET complexes is due to oleic acid and independent of the α-lactalbumin component. FEBS Open Bio 5, 397–404, 2015. doi: 10.1016/j.fob.2015.04.010.
   PubMed Web of Science ®Google Scholar
• Carrillo C, Cavia Mdel M, and Alonso-Torre S: Role of oleic acid in immune system; mechanism of action; a review. Nutr Hosp 27, 978–990, 2012. doi: 10.3305/nh.2012.27.4.5783.
   PubMed Web of Science ®Google Scholar
• Sugino T, Baba K, Hoshi N, Aikawa K, Yamaguchi O, et al.: Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients. Med Mol Morphol 44, 146–150, 2011. doi: 10.1007/s00795-010-0517-0.
   PubMed Web of Science ®Google Scholar
• Vinknes KJ, Elshorbagy AK, Nurk E, Drevon CA, Gjesdal CG, et al.: Plasma stearoyl-CoA desaturase indices: association with lifestyle, diet, and body composition. Obesity (Silver Spring) 21, E294–302, 2013. doi: 10.1002/oby.20011.
   PubMed Web of Science ®Google Scholar
• Jung JI, Cho HJ, Kim J, Kwon DY, and Park JH: Trans-10, cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells. J Med Food 13, 13–19, 2010. doi: 10.1089/jmf.2009.1201.
   PubMed Web of Science ®Google Scholar
• Wakai K, Takashi M, Okamura K, Yuba H, Suzuki K, et al.: Foods and nutrients in relation to bladder cancer risk: a case-control study in Aichi Prefecture, Central Japan. Nutr Cancer 38, 13–22, 2000.
   PubMed Web of Science ®Google Scholar
• Steinmaus CM, Nuñez S, and Smith AH: Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 151, 693–702, 2000.
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Augustin JL, Schaefer MM, Rasmussen H, Ordovas JM, et al.: Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr 71, 746–751, 2000.
   PubMed Web of Science ®Google Scholar